EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plant Secondary Metabolites as Next-Generation Antibiofilm and Antimicrobial Agents: Mechanisms, Synergistic Effects, and Clinical Translation

Saravanakumar Parameswaran, Satheesh Babu Natarajan, Nivetha Shanmugam, Anandarajagopal Kalusalingam

Drugs and Drug Candidates · 01.07.2026 · 5 (3) · 38

DOI: 10.3390/ddc5030038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs and Drug Candidates, online erschienen am 01.07.2026. Verfasst von Saravanakumar Parameswaran und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the most pressing challenges facing healthcare today is the rise of biofilm infections and antibiotic-resistant bacteria, which demand entirely new therapeutic strategies beyond conventional antibiotic reliance. A biofilm is a structured community of microorganisms encased in a self-produced extracellular polymeric substance (EPS) matrix, which confers resistance to host immune defenses and antimicrobial agents. Accumulating evidence demonstrates that plant-derived secondary metabolites—including flavonoids, phenolic acids, tannins, terpenoids, and alkaloids—exert potent antibacterial and antibiofilm activities through diverse mechanisms of action. These natural compounds inhibit biofilm formation by disrupting bacterial adhesion, suppressing quorum sensing, degrading the EPS matrix, and impairing bacterial motility. Beyond independent bioactivity, phytochemicals demonstrate significant synergistic potential when combined with conventional antibiotics, revitalizing antimicrobial efficacy against drug-resistant pathogens. Nanoformulation and biogenic carrier technologies further enhance the bioavailability and therapeutic potency of these compounds. Despite these advances, critical challenges persist, including poor bioavailability, physicochemical instability, dose-dependent toxicity, and the risk of resistance development. This review presents a critical and integrative analysis of the pharmacological mechanisms of plant secondary metabolites, with particular emphasis on their role in combating biofilm-associated infections and antibiotic resistance, and discusses translational opportunities including structure–activity relationship (SAR)-guided optimization, high-throughput screening platforms, and advanced drug delivery systems. Collectively, plant secondary metabolites represent a scientifically compelling and clinically relevant pipeline for the development of next-generation antimicrobial and antibiofilm therapeutics.

Zitieren

APA

Parameswaran, S., Natarajan, S. B., Shanmugam, N., & Kalusalingam, A. (2026). Plant Secondary Metabolites as Next-Generation Antibiofilm and Antimicrobial Agents: Mechanisms, Synergistic Effects, and Clinical Translation. Drugs and Drug Candidates, 5(3), 38. https://doi.org/10.3390/ddc5030038

Vancouver

Parameswaran S, Natarajan SB, Shanmugam N, Kalusalingam A. Plant Secondary Metabolites as Next-Generation Antibiofilm and Antimicrobial Agents: Mechanisms, Synergistic Effects, and Clinical Translation. Drugs and Drug Candidates. 2026;5(3):38. doi:10.3390/ddc5030038

BibTeX
@article{Parameswaran2026,
  author = {Parameswaran, Saravanakumar and Natarajan, Satheesh Babu and Shanmugam, Nivetha and Kalusalingam, Anandarajagopal},
  title = {Plant Secondary Metabolites as Next-Generation Antibiofilm and Antimicrobial Agents: Mechanisms, Synergistic Effects, and Clinical Translation},
  journal = {Drugs and Drug Candidates},
  year = {2026},
  volume = {5},
  number = {3},
  pages = {38},
  doi = {10.3390/ddc5030038}
}
Kostenlos starten →